The cell cycle regulator p27(kip1) contributes to growth and differentiation of osteoblasts

Hicham Drissi, Dennet Hushka, Fauzia Aslam, Que Nguyen, Elizabeth Buffone, Andrew Koff, Andre J van Wijnen, Jane B. Lian, Janet L. Stein, Gary S. Stein

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

The cyclin-dependent kinase (cdk) inhibitors are key regulators of cell cycle progression, p27 and p21 are members of the Cip/Kip family of cdk inhibitors and regulate cell growth by inactivating cell cycle stage-specific CDK-cyclin complexes. Because down-regulation of osteoprogenitor proliferation is a critical step for osteoblast differentiation, we investigated expression of p27 and p21 during development of the osteoblast phenotype in rat calvarial osteoblasts and in proliferating and growth- inhibited osteosarcoma ROS 17/2.8 cells. Expression of these proteins indicates that p21, which predominates in the growth period, is related to proliferation control, p27 levels are maximal postproliferatively, suggesting a role in the transition from cell proliferation to osteoblast differentiation. We directly examined the role of p27 during differentiation of osteoprogenitor cells derived from the bone marrow (BM) of p27(-/-) mice. BM cells from p27 null mice exhibited increased proliferative activity compared with BM cells from wild-type mice and formed an increased number and larger size of osteoblastic colonies, which further differentiated to the mineralization stage. Although p27(-/-) adherent marrow cells proliferate faster, they retain competency for differentiation, which may result, in part, from observed higher p21 levels compared with wild type. Histological studies of p27(-/-) bones also showed an increased cellularity in the marrow cavity compared with the p27(+/+). The increased proliferation in bone does not lead to tumorigenesis, in contrast to observed adenomas in the null mice. Taken together, these findings indicate that p27 plays a key role in regulating osteoblast differentiation by controlling proliferation-related events in bone cells.

Original languageEnglish (US)
Pages (from-to)3705-3711
Number of pages7
JournalCancer Research
Volume59
Issue number15
StatePublished - Aug 1 1999
Externally publishedYes

Fingerprint

Osteoblasts
Cell Cycle
Bone Marrow Cells
Growth
Cyclin-Dependent Kinases
Bone and Bones
Bone Marrow
Growth Inhibitors
Cyclins
Osteosarcoma
Adenoma
Carcinogenesis
Down-Regulation
Cell Proliferation
Phenotype
Proteins

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Drissi, H., Hushka, D., Aslam, F., Nguyen, Q., Buffone, E., Koff, A., ... Stein, G. S. (1999). The cell cycle regulator p27(kip1) contributes to growth and differentiation of osteoblasts. Cancer Research, 59(15), 3705-3711.

The cell cycle regulator p27(kip1) contributes to growth and differentiation of osteoblasts. / Drissi, Hicham; Hushka, Dennet; Aslam, Fauzia; Nguyen, Que; Buffone, Elizabeth; Koff, Andrew; van Wijnen, Andre J; Lian, Jane B.; Stein, Janet L.; Stein, Gary S.

In: Cancer Research, Vol. 59, No. 15, 01.08.1999, p. 3705-3711.

Research output: Contribution to journalArticle

Drissi, H, Hushka, D, Aslam, F, Nguyen, Q, Buffone, E, Koff, A, van Wijnen, AJ, Lian, JB, Stein, JL & Stein, GS 1999, 'The cell cycle regulator p27(kip1) contributes to growth and differentiation of osteoblasts', Cancer Research, vol. 59, no. 15, pp. 3705-3711.
Drissi H, Hushka D, Aslam F, Nguyen Q, Buffone E, Koff A et al. The cell cycle regulator p27(kip1) contributes to growth and differentiation of osteoblasts. Cancer Research. 1999 Aug 1;59(15):3705-3711.
Drissi, Hicham ; Hushka, Dennet ; Aslam, Fauzia ; Nguyen, Que ; Buffone, Elizabeth ; Koff, Andrew ; van Wijnen, Andre J ; Lian, Jane B. ; Stein, Janet L. ; Stein, Gary S. / The cell cycle regulator p27(kip1) contributes to growth and differentiation of osteoblasts. In: Cancer Research. 1999 ; Vol. 59, No. 15. pp. 3705-3711.
@article{2a754a3bde12483caded27e4ca18013b,
title = "The cell cycle regulator p27(kip1) contributes to growth and differentiation of osteoblasts",
abstract = "The cyclin-dependent kinase (cdk) inhibitors are key regulators of cell cycle progression, p27 and p21 are members of the Cip/Kip family of cdk inhibitors and regulate cell growth by inactivating cell cycle stage-specific CDK-cyclin complexes. Because down-regulation of osteoprogenitor proliferation is a critical step for osteoblast differentiation, we investigated expression of p27 and p21 during development of the osteoblast phenotype in rat calvarial osteoblasts and in proliferating and growth- inhibited osteosarcoma ROS 17/2.8 cells. Expression of these proteins indicates that p21, which predominates in the growth period, is related to proliferation control, p27 levels are maximal postproliferatively, suggesting a role in the transition from cell proliferation to osteoblast differentiation. We directly examined the role of p27 during differentiation of osteoprogenitor cells derived from the bone marrow (BM) of p27(-/-) mice. BM cells from p27 null mice exhibited increased proliferative activity compared with BM cells from wild-type mice and formed an increased number and larger size of osteoblastic colonies, which further differentiated to the mineralization stage. Although p27(-/-) adherent marrow cells proliferate faster, they retain competency for differentiation, which may result, in part, from observed higher p21 levels compared with wild type. Histological studies of p27(-/-) bones also showed an increased cellularity in the marrow cavity compared with the p27(+/+). The increased proliferation in bone does not lead to tumorigenesis, in contrast to observed adenomas in the null mice. Taken together, these findings indicate that p27 plays a key role in regulating osteoblast differentiation by controlling proliferation-related events in bone cells.",
author = "Hicham Drissi and Dennet Hushka and Fauzia Aslam and Que Nguyen and Elizabeth Buffone and Andrew Koff and {van Wijnen}, {Andre J} and Lian, {Jane B.} and Stein, {Janet L.} and Stein, {Gary S.}",
year = "1999",
month = "8",
day = "1",
language = "English (US)",
volume = "59",
pages = "3705--3711",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "15",

}

TY - JOUR

T1 - The cell cycle regulator p27(kip1) contributes to growth and differentiation of osteoblasts

AU - Drissi, Hicham

AU - Hushka, Dennet

AU - Aslam, Fauzia

AU - Nguyen, Que

AU - Buffone, Elizabeth

AU - Koff, Andrew

AU - van Wijnen, Andre J

AU - Lian, Jane B.

AU - Stein, Janet L.

AU - Stein, Gary S.

PY - 1999/8/1

Y1 - 1999/8/1

N2 - The cyclin-dependent kinase (cdk) inhibitors are key regulators of cell cycle progression, p27 and p21 are members of the Cip/Kip family of cdk inhibitors and regulate cell growth by inactivating cell cycle stage-specific CDK-cyclin complexes. Because down-regulation of osteoprogenitor proliferation is a critical step for osteoblast differentiation, we investigated expression of p27 and p21 during development of the osteoblast phenotype in rat calvarial osteoblasts and in proliferating and growth- inhibited osteosarcoma ROS 17/2.8 cells. Expression of these proteins indicates that p21, which predominates in the growth period, is related to proliferation control, p27 levels are maximal postproliferatively, suggesting a role in the transition from cell proliferation to osteoblast differentiation. We directly examined the role of p27 during differentiation of osteoprogenitor cells derived from the bone marrow (BM) of p27(-/-) mice. BM cells from p27 null mice exhibited increased proliferative activity compared with BM cells from wild-type mice and formed an increased number and larger size of osteoblastic colonies, which further differentiated to the mineralization stage. Although p27(-/-) adherent marrow cells proliferate faster, they retain competency for differentiation, which may result, in part, from observed higher p21 levels compared with wild type. Histological studies of p27(-/-) bones also showed an increased cellularity in the marrow cavity compared with the p27(+/+). The increased proliferation in bone does not lead to tumorigenesis, in contrast to observed adenomas in the null mice. Taken together, these findings indicate that p27 plays a key role in regulating osteoblast differentiation by controlling proliferation-related events in bone cells.

AB - The cyclin-dependent kinase (cdk) inhibitors are key regulators of cell cycle progression, p27 and p21 are members of the Cip/Kip family of cdk inhibitors and regulate cell growth by inactivating cell cycle stage-specific CDK-cyclin complexes. Because down-regulation of osteoprogenitor proliferation is a critical step for osteoblast differentiation, we investigated expression of p27 and p21 during development of the osteoblast phenotype in rat calvarial osteoblasts and in proliferating and growth- inhibited osteosarcoma ROS 17/2.8 cells. Expression of these proteins indicates that p21, which predominates in the growth period, is related to proliferation control, p27 levels are maximal postproliferatively, suggesting a role in the transition from cell proliferation to osteoblast differentiation. We directly examined the role of p27 during differentiation of osteoprogenitor cells derived from the bone marrow (BM) of p27(-/-) mice. BM cells from p27 null mice exhibited increased proliferative activity compared with BM cells from wild-type mice and formed an increased number and larger size of osteoblastic colonies, which further differentiated to the mineralization stage. Although p27(-/-) adherent marrow cells proliferate faster, they retain competency for differentiation, which may result, in part, from observed higher p21 levels compared with wild type. Histological studies of p27(-/-) bones also showed an increased cellularity in the marrow cavity compared with the p27(+/+). The increased proliferation in bone does not lead to tumorigenesis, in contrast to observed adenomas in the null mice. Taken together, these findings indicate that p27 plays a key role in regulating osteoblast differentiation by controlling proliferation-related events in bone cells.

UR - http://www.scopus.com/inward/record.url?scp=17444430336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17444430336&partnerID=8YFLogxK

M3 - Article

C2 - 10446985

AN - SCOPUS:17444430336

VL - 59

SP - 3705

EP - 3711

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 15

ER -